|
Q2 FY2025
As of Jun 29, 2025
|
Q1 FY2025
As of Mar 30, 2025
|
Q4 FY2024
As of Dec 29, 2024
|
Q3 FY2024
As of Sep 29, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 24, 2023
|
Q2 FY2023
As of Jun 25, 2023
|
Q1 FY2023
As of Mar 26, 2023
|
Q4 FY2022
As of Dec 25, 2022
|
Q3 FY2022
As of Sep 25, 2022
|
Q2 FY2022
As of Jun 26, 2022
|
Q1 FY2022
As of Mar 27, 2022
|
Q4 FY2021
As of Dec 26, 2021
|
Q3 FY2021
As of Sep 26, 2021
|
Q2 FY2021
As of Jun 27, 2021
|
Q1 FY2021
As of Mar 28, 2021
|
Q4 FY2020
As of Dec 27, 2020
|
Q3 FY2020
As of Sep 27, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowances of $40 and $22 as of June 29, 2025 and December 29, 2024, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Assets classified as held-for-sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Right-of-use assets for operating leases | ||||||||||||||||||||
| Indefinite-lived intangible assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Deferred expenses, net and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Short-term operating lease liabilities | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net of current portion | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Common stock, $0.01 par value—authorized 200,000 shares; outstanding 30,256 and 29,893 shares as of June 29, 2025, and December 29, 2024, respectively | ||||||||||||||||||||
| Warrants | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Treasury stock, held at cost, 10,836 and 10,445 shares as of June 29, 2025, and December 29, 2024, respectively | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
